CoChat
Sign Up
Cited by 76Psychopathy, Forensic Psychiatry, Sexual OffendingSexuality, Behavior, and TechnologySchizophrenia research and treatment

Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions

Turner, Daniel, Basdekis-Jozsa, Raphaela, Briken, Peer·2013·The Journal of Sexual Medicine
DOI 10.1111/j.1743-6109.2012.02958.x
Open this paper in CoChat — free account

Abstract

Introduction Different clinical guidelines suggest using testosterone-lowering medications (TLM) in sex offender treatment in addition to psychotherapy. Within Germany, there are two officially approved agents. So far, no current data exist about the routine use of TLM in a clinical context. Aim The present observational study evaluates the frequency of the prescription of TLM and other medications in sex offender treatment in German forensic-psychiatric institutions. Experts are asked about the observed effects and side effects of TLM. Method The heads of all 69 German forensic-psychiatric hospitals and outpatient clinics were asked to fill out a questionnaire assessing offender characteristics and treatment methods in use. Main outcome measures Main outcome measures were the number of patients being treated with TLM and other pharmacological agents for reducing sexual drive. Further effects and side effects of the agents were evaluated. Results Thirty-two participating institutions reported on 3,963 patients, 611 of them being sex offenders (15.4%). Most sex offenders had been convicted for child sexual abuse (39.8%) or a sexual assault/rape (37.6%). Almost all sex offenders were treated psychotherapeutically and 37% were receiving an additional pharmacological treatment. Of all the sex offenders, 15.7% were treated with TLM; 10.6% were treated with a gonadotropin-releasing hormone agonist; and 5.1% were treated with cyproterone acetate. Of these, 26.0-75.4% showed improvem…

Integrity signals

Registry

Crossref · 10.1111/j.1743-6109.2012.02958.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Of those receiving additional pharmacological treatment in the German survey, 15.7% were treated with testosterone-lowering medications (10.6% with a GnRH agonist and 5.1% with CPA); 11.5% with SSRIs, and 9.8% with antipsychotic medications.

    “Of the latter, 15.7% were treated with testosterone-lowering medications (10.6% with a GnRH agonist and 5.1% with CPA); 11.5% with SSRIs, and 9.8% with antipsychotic medications.”

    From Pharmacological interventions for those who have sexually offended or are at risk of offending (2015) · cites this paper as Turner 2013

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Turner, D., Basdekis-Jozsa, R., & Briken, P.
Affiliations
  • Universität Hamburg (DE)
  • Institute for Sex Research and Forensic Psychiatry, University of Hamburg , Hamburg , Germany
Corresponding author
Briken, Peer
ORCID
Venue
The Journal of Sexual Medicine
Publisher
Oxford University Press (OUP)
Published
2013-02-01
Volume
10
Issue
2
Pages
570-578
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
DOI
10.1111/j.1743-6109.2012.02958.x
OpenAlex
W1947804209
Cited by
76
References
1
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 6 · 2019: 2 · 2018: 10 · 2017: 13 · 2016: 5 · 2015: 4 · 2014: 6 · 2013: 1 · 2012: 1
FWCI
4.34
Type
journal article
Language
en
Open access
closed
Licence
academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
Locations
  • The Journal of Sexual Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
  • Social Sciences › Psychology › Clinical Psychology › Sexuality, Behavior, and Technology
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
sex offender treatment, forensic psychiatry, GnRH agonist, cyproterone acetate, child sexual abuse, sexual assault, selective serotonin reuptake inhibitors, antipsychotic drugs, adverse drug reactions, Germany
MeSH terms
Adult, Androgen Antagonists, Child, Child Abuse, Sexual, Combined Modality Therapy, Commitment of Persons with Psychiatric Disorders, Drive, Drug Therapy, Combination, Germany, Humans, Gonadotropin-Releasing Hormone, Libido, Male, Middle Aged, Paraphilic Disorders, Practice Patterns, Physicians', Psychotherapy, Surveys and Questionnaires, Rape, Sex Offenses, Testosterone, Antipsychotic Agents, Treatment Outcome, Triptorelin Pamoate, Selective Serotonin Reuptake Inhibitors, Cyproterone Acetate, Prescription Drugs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review